Top 4 Large-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Gilead Sciences Inc

is 47.98%. GILD's ROE for the same period is 45.47%. The trailing-twelve-month operating margin at Biogen Idec Inc

is 35.82%. BIIB's PEG ratio is 1.85. The trailing-twelve-month operating margin at Amgen Inc

is 33.97%. AMGN's revenue for the same period is $15.45 billion. The trailing-twelve-month operating margin at Celgene Corporation

is 32.99%. CELG's PEG ratio is 0.71.